, ::: frequency :::58
( ::: frequency :::6
is increased in ::: frequency :::5
or ::: frequency :::35
of ::: frequency :::16
; ::: frequency :::3
, including ::: frequency :::3
in ::: frequency :::26
Cystic ::: frequency :::2
for ::: frequency :::4
and ::: frequency :::134
, and ::: frequency :::6
( CT ) , and ::: frequency :::2
( MRI ) and computed ::: frequency :::3
( CT ) and ::: frequency :::19
or computed ::: frequency :::10
( CT ) or ::: frequency :::18
( CT ) and/or ::: frequency :::3
( CT ) scans or ::: frequency :::2
, PSC primary sclerosing ::: frequency :::2
and computed ::: frequency :::3
( MRI ) or computed ::: frequency :::5
: ::: frequency :::4
( CT ) , ::: frequency :::5
is ::: frequency :::3
from ::: frequency :::2
with ::: frequency :::5
; MRI , ::: frequency :::5
( MRI ) , computed ::: frequency :::2
by ::: frequency :::2
, or ::: frequency :::4
( MDCT ) and ::: frequency :::3
; SVT : sustained ::: frequency :::2
, where ::: frequency :::2
including ::: frequency :::2
and allied ::: frequency :::2
in general or ::: frequency :::3
in general and ::: frequency :::3
like ::: frequency :::2
but not ::: frequency :::3
) . For ::: frequency :::2
. In ::: frequency :::3
, TTH , and ::: frequency :::2
, TTH and ::: frequency :::2
with Peg-INF-Î± based ::: frequency :::2
